198 related articles for article (PubMed ID: 36371486)
1. Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells.
Siegner SM; Ugalde L; Clemens A; Garcia-Garcia L; Bueren JA; Rio P; Karasu ME; Corn JE
Nat Commun; 2022 Nov; 13(1):6900. PubMed ID: 36371486
[TBL] [Abstract][Full Text] [Related]
2. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
[TBL] [Abstract][Full Text] [Related]
3. Correction of Fanconi Anemia Mutations Using Digital Genome Engineering.
Sipe CJ; Kluesner MG; Bingea SP; Lahr WS; Andrew AA; Wang M; DeFeo AP; Hinkel TL; Laoharawee K; Wagner JE; MacMillan ML; Vercellotti GM; Tolar J; Osborn MJ; McIvor RS; Webber BR; Moriarity BS
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955545
[TBL] [Abstract][Full Text] [Related]
4. Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair.
van de Vrugt HJ; Harmsen T; Riepsaame J; Alexantya G; van Mil SE; de Vries Y; Bin Ali R; Huijbers IJ; Dorsman JC; Wolthuis RMF; Te Riele H
Sci Rep; 2019 Jan; 9(1):768. PubMed ID: 30683899
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic gene editing in CD34
Diez B; Genovese P; Roman-Rodriguez FJ; Alvarez L; Schiroli G; Ugalde L; Rodriguez-Perales S; Sevilla J; Diaz de Heredia C; Holmes MC; Lombardo A; Naldini L; Bueren JA; Rio P
EMBO Mol Med; 2017 Nov; 9(11):1574-1588. PubMed ID: 28899930
[TBL] [Abstract][Full Text] [Related]
6. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
[TBL] [Abstract][Full Text] [Related]
7. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
[TBL] [Abstract][Full Text] [Related]
8. Non-homologous end-joining defect in fanconi anemia hematopoietic cells exposed to ionizing radiation.
Casado JA; Núñez MI; Segovia JC; Ruiz de Almodóvar JM; Bueren JA
Radiat Res; 2005 Nov; 164(5):635-41. PubMed ID: 16238440
[TBL] [Abstract][Full Text] [Related]
9. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.
Tulpule A; Lensch MW; Miller JD; Austin K; D'Andrea A; Schlaeger TM; Shimamura A; Daley GQ
Blood; 2010 Apr; 115(17):3453-62. PubMed ID: 20089964
[TBL] [Abstract][Full Text] [Related]
11. Advances in Gene Therapy for Fanconi Anemia.
Río P; Navarro S; Bueren JA
Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
[TBL] [Abstract][Full Text] [Related]
13. Base editing of haematopoietic stem cells rescues sickle cell disease in mice.
Newby GA; Yen JS; Woodard KJ; Mayuranathan T; Lazzarotto CR; Li Y; Sheppard-Tillman H; Porter SN; Yao Y; Mayberry K; Everette KA; Jang Y; Podracky CJ; Thaman E; Lechauve C; Sharma A; Henderson JM; Richter MF; Zhao KT; Miller SM; Wang T; Koblan LW; McCaffrey AP; Tisdale JF; Kalfa TA; Pruett-Miller SM; Tsai SQ; Weiss MJ; Liu DR
Nature; 2021 Jul; 595(7866):295-302. PubMed ID: 34079130
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells.
Skvarova Kramarzova K; Osborn MJ; Webber BR; DeFeo AP; McElroy AN; Kim CJ; Tolar J
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28613254
[TBL] [Abstract][Full Text] [Related]
15. Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress.
Zhang T; Wilson AF; Mahmood Ali A; Namekawa SH; Andreassen PR; Ruhikanta Meetei A; Pang Q
Stem Cells; 2015 Jul; 33(7):2320-30. PubMed ID: 25917546
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic adenine base editing of human hematopoietic stem cells.
Liao J; Chen S; Hsiao S; Jiang Y; Yang Y; Zhang Y; Wang X; Lai Y; Bauer DE; Wu Y
Nat Commun; 2023 Jan; 14(1):207. PubMed ID: 36639729
[TBL] [Abstract][Full Text] [Related]
17. Targeted gene therapy and cell reprogramming in Fanconi anemia.
Rio P; Baños R; Lombardo A; Quintana-Bustamante O; Alvarez L; Garate Z; Genovese P; Almarza E; Valeri A; Díez B; Navarro S; Torres Y; Trujillo JP; Murillas R; Segovia JC; Samper E; Surralles J; Gregory PD; Holmes MC; Naldini L; Bueren JA
EMBO Mol Med; 2014 Jun; 6(6):835-48. PubMed ID: 24859981
[TBL] [Abstract][Full Text] [Related]
18. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
[TBL] [Abstract][Full Text] [Related]
19. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer?
Martínez-Balsalobre E; Guervilly JH; van Asbeck-van der Wijst J; Pérez-Oliva AB; Lachaud C
Blood Rev; 2023 Jul; 60():101094. PubMed ID: 37142543
[TBL] [Abstract][Full Text] [Related]
20. Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.
González-Murillo A; Lozano ML; Alvarez L; Jacome A; Almarza E; Navarro S; Segovia JC; Hanenberg H; Guenechea G; Bueren JA; Río P
Hum Gene Ther; 2010 May; 21(5):623-30. PubMed ID: 20001454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
